Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Regentatlantic Capital LLC

Regentatlantic Capital LLC reduced its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.9% in the second quarter, HoldingsChannel.com reports. The fund owned 30,093 shares of the pharmacy operator’s stock after selling 1,215 shares during the quarter. Regentatlantic Capital LLC’s holdings in Walgreens Boots Alliance were worth $1,583,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently modified their holdings of WBA. Stonebridge Capital Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $27,000. Loomis Sayles & Co. L P bought a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $33,000. Red Door Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the second quarter valued at approximately $35,000. Centerpoint Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 203.8% during the second quarter. Centerpoint Advisors LLC now owns 711 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 477 shares during the last quarter. Finally, Strategic Blueprint LLC bought a new stake in shares of Walgreens Boots Alliance during the second quarter valued at approximately $38,000. Institutional investors own 55.65% of the company’s stock.

Walgreens Boots Alliance stock opened at $48.31 on Friday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.53 and a current ratio of 0.77. The firm has a market cap of $41.79 billion, a price-to-earnings ratio of 18.30, a price-to-earnings-growth ratio of 1.41 and a beta of 0.49. Walgreens Boots Alliance, Inc. has a 1 year low of $33.36 and a 1 year high of $57.05. The firm’s 50 day moving average price is $48.50 and its two-hundred day moving average price is $51.28.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, June 30th. The pharmacy operator reported $1.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.17 by $0.21. The firm had revenue of $34.03 billion for the quarter, compared to analyst estimates of $33.47 billion. Walgreens Boots Alliance had a net margin of 1.66% and a return on equity of 20.79%. The firm’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.71 earnings per share. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 4.75 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 10th. Shareholders of record on Friday, August 20th were given a dividend of $0.477 per share. This represents a $1.91 annualized dividend and a yield of 3.95%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. The ex-dividend date was Thursday, August 19th. Walgreens Boots Alliance’s payout ratio is presently 40.30%.

A number of equities research analysts have recently weighed in on the company. Evercore ISI reaffirmed a “hold” rating and set a $52.00 price target on shares of Walgreens Boots Alliance in a report on Friday, July 2nd. Credit Suisse Group cut their price target on Walgreens Boots Alliance from $50.00 to $48.00 and set a “neutral” rating on the stock in a report on Friday, July 2nd. Truist Securities dropped their target price on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a report on Friday, July 2nd. TheStreet cut Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a report on Friday, June 18th. Finally, Truist dropped their target price on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a report on Friday, July 2nd. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $50.83.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

Recommended Story: Percentage Gainers

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.